It has been suggested that HAX1 is a major inhibitor of apoptosis in myeloid cells and that neutropenia in HAX1-deficient SCN patients is caused by lack of this antiapoptotic function [49]. This evidence concerns the gene HAX1 and severe congenital neutropenia.